Sign Out
Pregnancy: There are no specific study on the use of OPTIVE/OPTIVE UD during pregnancy and lactation in humans. However, animal studies with CMC have not demonstrated any harmful effects in pregnancy. Animal studies using glycerin have shown no evidence of teratogenicity.
Lactation: OPTIVE/OPTIVE UD has also not been studied in breast-feeding women; however, OPTIVE/OPTIVE UD is not expected to have significant systemic absorption; therefore, it would not be excreted in human breast milk.
Continue with Google